From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

I am Deadly Sirius - I have gone short

By Lucian Miers | Sunday 20 March 2016


Disclosure: The author has a short position in one or more of the shares mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Those who listened to Australian fund manager John Hempton speak at the Gold and Bears show last November will know that attention to detail is very much his thing. They will have heard him mutter that he believed US Pharmaceutical giant Valeant, based in Canada, to be worthless. This has been a bold call with ranks of hedge fund royalty (the most prominent being the unbelievably arrogant Bill Ackman) lined up against him.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CTAI

Catenai – monster dilution

Time left: 13:45:24